News | Atrial Fibrillation | May 17, 2023

Jasmina Brooks Named President of Biosense Webster

Jasmina Brooks

Jasmina Brooks 


May 17, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmiatreatment and part of Johnson & Johnson MedTech, announced that Jasmina (Jass) Brooks as President, Biosense Webster. In this role, Brooks will have accountability for setting Biosense Webster’s global strategy, and advancing its innovation agenda, to position the organization for continued growth. Brooks succeeds Michael Bodner, Ph.D. who has assumed the role of Global Head of Heart Recovery for Johnson & Johnson MedTech. 

Brooks comes to the role with nearly 25 years of experience in the cardiovascular field, primarily focused on electrophysiology. She is a nine-year veteran of Biosense Webster, and her background is ideally suited to assume leadership of the organization and oversee its next phase of innovation and growth.  

Most recently, Brooks was Vice President, Global Strategic Marketing, Biosense Webster. In this role, she worked with cross-functional and international teams to set the strategy and shape the company product pipeline to drive growth, market share, and profitability. Brooks joined Biosense Webster in 2014 and held positions of increasing scope and responsibility in the Global Strategic Marketing Organization. Prior to joining Johnson & Johnson, Brooks spent 15 years at GE Healthcare, where she held various roles in commercial marketing, global strategic marketing, product development and engineering in the US and EMEA. Brooks holds a Bachelor of Science in Biomedical Engineering from Louisiana Tech University.  

“Jass Brooks is a well-respected, collaborative leader with a deep knowledge of the electrophysiology space, a track record of successfully driving growth and market leadership, as well as a deep commitment to developing talent and fostering a culture of collaboration and inclusivity,” said Celine Martin, Company Group Chairman, Cardiovascular & Specialty Solutions Group, Johnson & Johnson. “Jass has dedicated her career to championing excellence in patient outcomes and solving unmet medical needs, and she will continue to harness this passion in leading Biosense Webster as the company advances innovation solutions to help people with Afib live the lives they want.”  

“It is an honor to lead Biosense Webster, with its proud legacy and unmatched capabilities in cardiac catheter ablation,” said Brooks. “I look forward to continuing to partner closely with the electrophysiology community to elevate standards of care in AFib.” 

For more information: www.biosensewebster.com 


Related Content

News | Cardiovascular Business

September 21, 2023 — Many of the nation’s most prominent cardiovascular organizations, representing tens of thousands of ...

Home September 21, 2023
Home
News | Cardiovascular Business

September 15, 2023 — The American College of Cardiology (ACC) has recognized five Hackensack Meridian Health hospitals ...

Home September 15, 2023
Home
Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD

The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...

Home September 12, 2023
Home
News | Cardiovascular Business

September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing ...

Home September 11, 2023
Home
News | Cardiovascular Business

September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

Home September 11, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

As we wind down the summer months, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com ...

Home August 31, 2023
Home
Feature | Cardiovascular Business

August 22, 2023 — Leaders at University Hospitals (UH) Harrington Heart & Vascular Institute are saddened to share news ...

Home August 22, 2023
Home
News | Cardiovascular Business

August 17, 2023 — MemorialCare, a prominent nonprofit Southern California integrated health system, announced today that ...

Home August 17, 2023
Home
News | Cardiovascular Business

August 10, 2023 — It is the position of SCAI that ABIM diplomates who successfully pass their exams and report ...

Home August 10, 2023
Home
News | Cardiovascular Business

August 2, 2023 — Dr. Doria Scortichini, MD FACC joins the growing Auburn Heart Institute that is affiliated with Auburn ...

Home August 02, 2023
Home
Subscribe Now